Kalshi
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2029?
46%chance
– 0.0pt
Kalshi traders are currently pricing "Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2029?" at a 46% probability, roughly flat over the last 23h (0 point change).
- Volume (24h)
- $0
- Total volume
- $2.5K
- Liquidity
- $0
- Open interest
- $445
- All-time range
- 46% – 53%
- Our history
- 8 days
- Resolves
- 27mo
How this resolves
If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2029, then the market resolves to Yes.
Resolution rules as published by Kalshi — MeleeMarkets doesn't set or interpret these, we just mirror them.
Odds are mirrored from Kalshi's public market data and may lag the live order book slightly. Informational only — not financial advice. How we source data.